Y.D. More Investments Ltd Sells 621,098 Shares of DarioHealth Corp. $DRIO

Y.D. More Investments Ltd lowered its stake in shares of DarioHealth Corp. (NASDAQ:DRIO) by 95.0% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 32,684 shares of the company’s stock after selling 621,098 shares during the period. Y.D. More Investments Ltd’s holdings in DarioHealth were worth $567,000 at the end of the most recent reporting period.

Separately, XTX Topco Ltd increased its stake in DarioHealth by 229.0% in the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock valued at $42,000 after acquiring an additional 43,513 shares during the last quarter. Hedge funds and other institutional investors own 33.39% of the company’s stock.

Analyst Upgrades and Downgrades

DRIO has been the topic of a number of research reports. Stifel Nicolaus set a $16.00 price target on DarioHealth in a research report on Friday, November 14th. Wall Street Zen cut DarioHealth from a “hold” rating to a “sell” rating in a report on Sunday, January 25th. TD Cowen restated a “hold” rating on shares of DarioHealth in a research report on Friday, November 14th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DarioHealth in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $38.00.

DarioHealth Stock Down 1.4%

DRIO opened at $11.27 on Friday. DarioHealth Corp. has a 12 month low of $5.93 and a 12 month high of $17.74. The company has a current ratio of 4.55, a quick ratio of 4.02 and a debt-to-equity ratio of 0.41. The business’s 50-day moving average price is $11.34 and its 200-day moving average price is $11.69. The company has a market cap of $76.19 million, a P/E ratio of -1.01 and a beta of 1.16.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.